Infanrix-IPV+Hib

Infanrix-IPV+Hib Overdosage

Manufacturer:

GlaxoSmithKline Indonesia
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Overdosage
Some cases of overdose have been reported during post-marketing surveillance. Adverse events, when reported following overdosage, were similar to those observed after administration of the recommended dose of Infanrix-IPV+Hib.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in